Financial Performance - Operating revenue rose by 21.26% to CNY 398,668,166.05 year-on-year[7] - Net profit attributable to shareholders increased by 51.82% to CNY 121,972,883.59 compared to the same period last year[14] - Basic and diluted earnings per share increased by 33.33% to CNY 0.12[7] - Total operating revenue for Q1 2015 was CNY 398,668,166.05, an increase of 21.2% compared to CNY 328,765,960.94 in the same period last year[30] - Net profit for Q1 2015 reached CNY 121,229,214.87, up 52.4% from CNY 79,622,002.35 in Q1 2014[30] - Operating profit for the quarter was CNY 143,509,801.65, representing a 54.4% increase from CNY 92,896,534.52 in the previous year[30] - The company reported a total comprehensive income of CNY 125,921,214.87 for Q1 2015, compared to CNY 79,086,502.35 in Q1 2014, marking a 59.0% increase[31] - Investment income for the quarter was CNY 2,400,838.53, up from CNY 2,101,646.77 in the same period last year[30] Cash Flow - Net cash flow from operating activities decreased by 47.18% to CNY 53,478,550.20[7] - The net cash flow from operating activities decreased to CNY 53,478,550.20, down 47.3% from CNY 101,242,967.93 in Q1 2014[35] - The net cash flow from investment activities was -CNY 10,325,641.36, primarily due to increased investment in the construction of insulin analog (glargine) production base[18] - The net cash flow from financing activities was -CNY 9,187,966.70, compared to -CNY 117,264,602.62 in Q1 2014, indicating improved cash management[36] - Cash inflow from financing activities was CNY 0.00, a decrease from CNY 30,000,000.00 in the same period last year[36] - Cash outflow for purchasing goods and services increased significantly to CNY 161,440,013.91, up 68.8% from CNY 95,665,109.99 in the previous year[35] - The ending cash and cash equivalents balance increased to CNY 235,840,855.33, up from CNY 190,119,067.11 at the end of Q1 2014[36] - The company received CNY 270,000.00 in tax refunds, compared to CNY 0.00 in the previous year, indicating improved tax recovery[35] Assets and Liabilities - Total assets increased by 3.67% to CNY 3,064,632,425.58 compared to the end of the previous year[7] - The company's total assets increased to CNY 3,064,632,425.58 from CNY 2,956,219,432.05 at the beginning of the year[25] - The total current assets rose to CNY 1,441,961,703.47, up from CNY 1,311,767,949.79 at the beginning of the year[22] - The company's total liabilities decreased to CNY 778,207,192.27 from CNY 795,715,413.61, indicating a reduction in financial obligations[25] - The company's total liabilities amounted to CNY 729,435,283.76, slightly down from CNY 737,512,121.74 in the previous quarter[30] - The total equity attributable to shareholders increased to CNY 2,264,412,729.41 from CNY 2,137,747,845.82, reflecting a strong retained earnings position[25] - The company's total equity increased to CNY 2,386,104,717.98 from CNY 2,259,058,890.11 in the previous quarter[30] Shareholder Information - The number of shareholders reached 53,136 at the end of the reporting period[11] - The largest shareholder, Dongbao Industrial Group Co., Ltd., holds 37.27% of the shares[11] Operational Efficiency - Significant increase in prepayments by 233.72% to CNY 165,859,777.18 compared to the beginning of the year[13] - Accounts receivable increased to CNY 408,122,028.04 from CNY 392,171,982.06, reflecting a growth in sales[22] - Prepayments surged to CNY 165,859,777.18 from CNY 49,700,806.04, indicating increased material purchases[22] - Inventory decreased to CNY 592,887,213.62 from CNY 629,582,729.56, suggesting improved inventory management[22] - Total operating costs for the quarter were CNY 257,559,202.93, an increase of 8.2% from CNY 237,971,073.19 in the same period last year[30] - The company’s sales expenses rose to CNY 104,182,070.80, an increase of 19.3% compared to CNY 87,280,931.85 in Q1 2014[30] - The cash outflow for employee payments rose to CNY 26,372,139.11, an increase of 17.5% from CNY 22,403,141.15 in Q1 2014[35] - The cash inflow from other operating activities was CNY 18,220,806.73, significantly higher than CNY 1,714,102.24 in the same period last year, reflecting enhanced operational efficiency[35] Financial Expenses - Financial expenses rose by 107.71% to CNY 9,143,604.33 due to the completion of the project[14]
通化东宝(600867) - 2015 Q1 - 季度财报